Back
SAB Biotherapeutics, Inc. SABS · Insights
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of... Price3.1
Market Cap287.81 M
Float90 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro